Davidson TM, Lebreton CL, Hendricksen AEW, Atkinson HJ, et al. Results of TRIO-15, a multicenter, open-label, phase II study of the efficacy and safety of ganitumab in patients with recurrent platinum-sensitive ovarian cancer. Gynecol Oncol 2023;170:221-228.
PMID: 36709663